[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2022 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
09-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- -3.56%
YoY- 5.97%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 735,982 801,900 696,717 726,342 735,366 743,764 639,175 9.88%
PBT 89,610 113,168 84,851 92,672 96,238 106,584 82,983 5.27%
Tax -19,266 -22,636 -14,739 -22,070 -23,034 -25,420 -17,300 7.46%
NP 70,344 90,532 70,112 70,601 73,204 81,164 65,683 4.68%
-
NP to SH 70,344 90,532 70,112 70,601 73,204 81,164 65,683 4.68%
-
Tax Rate 21.50% 20.00% 17.37% 23.82% 23.93% 23.85% 20.85% -
Total Cost 665,638 711,368 626,605 655,741 662,162 662,600 573,492 10.47%
-
Net Worth 670,448 666,567 657,045 647,522 634,375 621,987 621,564 5.19%
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div 9,577 - 21,901 6,348 9,468 - 21,660 -42.04%
Div Payout % 13.62% - 31.24% 8.99% 12.93% - 32.98% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth 670,448 666,567 657,045 647,522 634,375 621,987 621,564 5.19%
NOSH 961,942 952,239 952,239 952,239 952,239 941,765 941,765 1.42%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 9.56% 11.29% 10.06% 9.72% 9.95% 10.91% 10.28% -
ROE 10.49% 13.58% 10.67% 10.90% 11.54% 13.05% 10.57% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 76.84 84.21 73.17 76.28 77.67 80.12 67.87 8.65%
EPS 7.36 9.52 7.39 7.45 7.76 8.76 6.98 3.60%
DPS 1.00 0.00 2.30 0.67 1.00 0.00 2.30 -42.69%
NAPS 0.70 0.70 0.69 0.68 0.67 0.67 0.66 4.01%
Adjusted Per Share Value based on latest NOSH - 952,239
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 76.51 83.36 72.43 75.51 76.45 77.32 66.45 9.88%
EPS 7.31 9.41 7.29 7.34 7.61 8.44 6.83 4.64%
DPS 1.00 0.00 2.28 0.66 0.98 0.00 2.25 -41.84%
NAPS 0.697 0.6929 0.683 0.6731 0.6595 0.6466 0.6462 5.18%
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 1.30 1.56 1.61 1.30 1.20 1.49 1.68 -
P/RPS 1.69 1.85 2.20 1.70 1.55 1.86 2.48 -22.61%
P/EPS 17.70 16.41 21.87 17.53 15.52 17.04 24.09 -18.62%
EY 5.65 6.09 4.57 5.70 6.44 5.87 4.15 22.90%
DY 0.77 0.00 1.43 0.51 0.83 0.00 1.37 -31.96%
P/NAPS 1.86 2.23 2.33 1.91 1.79 2.22 2.55 -19.01%
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 24/08/23 22/05/23 23/02/23 09/11/22 16/08/22 17/05/22 15/02/22 -
Price 1.19 1.44 1.65 1.39 1.34 1.51 1.60 -
P/RPS 1.55 1.71 2.26 1.82 1.73 1.88 2.36 -24.50%
P/EPS 16.20 15.15 22.41 18.75 17.33 17.27 22.94 -20.74%
EY 6.17 6.60 4.46 5.33 5.77 5.79 4.36 26.12%
DY 0.84 0.00 1.39 0.48 0.75 0.00 1.44 -30.25%
P/NAPS 1.70 2.06 2.39 2.04 2.00 2.25 2.42 -21.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment